Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

Removing hair wrapped around the labia quickly prevents serious tissue damage.

COVID-19 may affect reproductive and urinary systems, needing more research for better care.

COVID-19 may worsen symptoms of benign prostatic hyperplasia (BPH).

Excessive pre-ejaculation can be treated with certain medications.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Managing malignant ureteral obstruction is challenging and requires personalized treatment to protect kidney function and patient health.

A vaccine may prevent benign prostatic hyperplasia (BPH).

Finasteride and dutasteride can affect sexual function in BPH patients.

Ultrasound shows 96% of young men with erectile dysfunction after using finasteride have abnormal penile tissue.

Dutasteride is more effective than finasteride for hair loss treatment.

Older age is the main risk factor for hemorrhagic cystitis after stem cell transplants.

Urinary PSA could be an early marker for enlarged prostate.

Taking alfuzosin and finasteride together caused temporary vision loss in a glaucoma patient, but switching to tamsulosin helped.

Finasteride and dutasteride can cause severe, lasting side effects.

Lycopene protects against testicular damage caused by finasteride.

Finasteride can treat prostatic haematuria, but its use is controversial.

Platelet-rich plasma can improve erectile function in older individuals by reducing prostate enlargement.

Men with self-diagnosed PFS-related ED have normal erectile hemodynamics.

Finasteride treatment may cause erectile dysfunction, but stopping it reverses these effects.

Cuscuta reflexa extract may help treat benign prostatic hyperplasia by reducing inflammation and oxidative stress.

Two German shepherds with acute prostatitis were successfully treated with medication.

New treatments and diagnostic methods for urological conditions show promise, but some lack sufficient accuracy for clinical use.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Finasteride's sexual side effects may be due to nocebo effect.